Metal Allergy Testing
Patch testing with metal salts (nickel, cobalt, chromium) is the gold standard diagnostic test for suspected metal allergy, with readings at day 2, day 4, and critically at day 7 to capture delayed reactions 1.
When to Test
Do NOT perform routine screening patch testing before implant surgery in patients without a history of metal allergy or prior implant complications 2, 3. The evidence shows that positive patch tests do not reliably predict clinical complications from implants 4, 3.
Test only when:
- Patient has persistent unexplained symptoms after adequate healing time following implant placement 2
- History of clinically significant metal intolerance (not just jewelry reactions) 3
- Prior implant complications suspected to be allergic 3
- Persistent dermatitis, pain, effusions, or implant loosening without other explanation 5
Testing Protocol
Patch Testing Methodology
- Apply standardized baseline series including metal salts (nickel, cobalt, potassium dichromate) 1
- Critical timing: Read at day 2, day 4, AND day 7 - the third reading captures approximately 10% additional positive reactions missed earlier 1
- Grade reactions as +, ++, or +++ 1
- Read in natural daylight to avoid misinterpretation 1
Important Caveats
Metal salts (nickel, cobalt, potassium dichromate) frequently cause irritant reactions that are easily misclassified as true allergic responses 1. This is the most common pitfall in metal allergy testing. Ensure experienced interpretation to distinguish irritant from allergic reactions.
Diagnostic Approach for Implant-Related Symptoms
- Exclude differential diagnoses first - infection, mechanical failure, aseptic loosening 5
- Allow adequate healing time - reactions typically occur weeks to months post-implant 2, 4
- Obtain standardized medical history with questionnaire-aided assessment 2
- Perform patch testing with late day 7 reading 1, 2
- Consider histology of peri-implant tissue if available 5
Role of In Vitro Testing
The lymphocyte transformation test (LTT) has too many limitations and lacks standardization to be generally recommended 2, 5. While it may indicate sensitization, interpretation is problematic and should not guide clinical decisions 5.
Management After Positive Testing
Conservative management with topical/oral corticosteroids often achieves good outcomes 4. Implant removal is reserved for:
- Confirmed metal hypersensitivity WITH implant failure 4
- Persistent symptoms despite conservative treatment 4
When revision is needed, consider titanium or oxidized zirconium alloys as alternatives 4.
Key Clinical Points
The most commonly implicated metals are nickel, cobalt, and chromium 6, 5. Reactions manifest as local or systemic contact dermatitis, impaired wound healing, effusions, pain, or loosening 5. Despite positive patch tests being common (up to 20% of population has metal sensitization 7), actual implant complications from metal allergy remain rare 2, 3.
The critical distinction: A positive patch test indicates sensitization but does NOT predict clinical complications from implants 4, 3. Clinical relevance must be established through correlation with symptoms, timing, and exclusion of other causes before attributing complications to metal allergy 2, 3, 8.